Top Markets
Coin of the day
Cell MedX Corp. Cell MedX Corp.

Cell MedX Corp.

CMXC
Rank in Stocks #30406
Cell MedX Corp. is a biotechnology firm dedicated to identifying, developing,... Cell MedX Corp. is a biotechnology firm dedicated to identifying, developing, and marketing both therapeutic and non-therapeutic solutions aimed at individuals suffering from conditions such as diabetes, Parkinson's disease, hypertension, neuropathy, and various kidney-related ailments. The company's offerings include the eBalance Pro System, designed for clinical application by medical professionals, and the eBalance Home System, intended for personal use to promote general well-being and alleviate pain. Both systems are managed by the eBalance Console, a central control unit featuring three distinct pre-programmed microcurrent algorithms: wellness, pain management, and a dual mode. Originally established in 2010 as Sports Asylum, Inc., the company adopted its current name, Cell MedX Corp., in September 2014. Its operations are headquartered in Carson City, Nevada.
Share Price
$0.41
Last synced: 2024-12-24
Market Cap
$16.96M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Cell MedX Corp. (CMXC)

Category

Price of CMXC with the market cap of B
Cell MedX Corp. Cell MedX Corp.
CMXC
$0.41
Market Capitalization of Cell MedX Corp.(CMXC)
Market Cap: $16.96M
As of August 2026 Cell MedX Corp. has a market cap of $16.96M. This makes Cell MedX Corp. the world's 30406th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Cell MedX Corp. from 2013 to 2026
CMXC compared with Top 5 Most Popular stocks
Price of CMXC Asset B Mkt. of B Results
Cell MedX Corp. Cell MedX Corp.
$128,272 $16.96M
$5.307T +31,285,805.23%
Cell MedX Corp. Cell MedX Corp.
$110,002 $16.96M
$4.551T +26,829,562.73%
Cell MedX Corp. Cell MedX Corp.
$100,420 $16.96M
$4.154T +24,492,701.23%
Cell MedX Corp. Cell MedX Corp.
$86,743.40 $16.96M
$3.589T +21,156,826.18%
Cell MedX Corp. Cell MedX Corp.
$67,606.20 $16.96M
$2.797T +16,489,216.79%